Status:
NOT_YET_RECRUITING
Cannabis Reduction and Functional Outcomes
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Conditions:
Cannabis Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing...
Eligibility Criteria
Inclusion
- Age 18+
- Urinary cannabinoid level ≥ 50 ng/mL
- DSM-5 diagnosis of CUD (mild, moderate, or severe)
- Willingness to attempt cannabis reduction
- Completion of Intake Visit
Exclusion
- Serious medical/psychiatric conditions
- Pregnancy or breastfeeding
- Use of cannabis in past 30 days was for medical purposes only
- Discontinuation or reduction of cannabis use may exacerbate a pre-existing condition
- TICS score ≤ 19
Key Trial Info
Start Date :
April 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2030
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT07218471
Start Date
April 1 2026
End Date
January 30 2030
Last Update
October 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.